0.87 USD
▼-0.01-1.56%
盘后 0.90 +3.89%
2026-11-20
市值
$22.74M
市盈率
—
EPS
-0.15
股息率
—
52 周区间
0.71 – 2.89
成交量
39.05K
Beta
0.50
目标价
—
52W 低 0.7152W 高 2.89
价格走势
公司简介
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ...